Probio-X Relieves Symptoms of Hyperlipidemia by Regulating Patients’ Gut Microbiome, Blood Lipid Metabolism, and Lifestyle Habits
Microbiology Spectrum · 15.06.2023 · 11 (3)
DOI: 10.1128/spectrum.04440-22 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Microbiology Spectrum, erschienen am 15.06.2023. Verfasst von Huan Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China. Hauptthemen laut MEDLINE: Bifidobacterium animalis, Gastrointestinal Microbiome, Hyperlipidemias, Probiotics. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology of Inner Mongolia, National Natural Science Foundation of China, Government of Inner Mongolia Autonomous Region.
Abstract (Originalsprache)
The human gut microbiota have a potential effect on the lipid metabolism and are closely related to the disease hyperlipidemia. Our trial has demonstrated that 3-month intake of a mixed probiotic formulation alleviates hyperlipidemic symptoms, possibly by modulation of gut microbes and host lipid metabolism. The findings of the present study provide new insights into the treatment of hyperlipidemia, mechanisms of novel therapeutic strategies, and application of probiotics-based therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Nutrition, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China.
- Inner Mongolia Key Laboratory of Nutrition and Health, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China.
- Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering, Inner Mongolia Agricultural University, Hohhot, Inner Mongolia, China.
- Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs, Inner Mongolia Agricultural University, Hohhot, Inner Mongolia, China.
- Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University, Hohhot, Inner Mongolia, China.
ORCID-Profile: Zhihong Sun, Ruifang Guo
Förderung
- Department of Science and Technology of Inner Mongolia
- National Natural Science Foundation of China
- Government of Inner Mongolia Autonomous Region
- 山东省农业农村厅 | Modern Agricultural Technology Industry System of Shandong province
Zitieren
APA
Wang, H., Ma, C., Li, Y., Zhang, L., A, L., Yang, C., Zhao, F., Han, H., Shang, D., Yang, F., Zhang, Y., Zhang, H., Sun, Z., & Guo, R. (2023). Probio-X Relieves Symptoms of Hyperlipidemia by Regulating Patients’ Gut Microbiome, Blood Lipid Metabolism, and Lifestyle Habits. Microbiology Spectrum, 11(3). https://doi.org/10.1128/spectrum.04440-22
Vancouver
Wang H, Ma C, Li Y, Zhang L, A L, Yang C, et al. Probio-X Relieves Symptoms of Hyperlipidemia by Regulating Patients’ Gut Microbiome, Blood Lipid Metabolism, and Lifestyle Habits. Microbiology Spectrum. 2023;11(3). doi:10.1128/spectrum.04440-22
BibTeX
@article{Wang2023,
author = {Wang, Huan and Ma, Cuicui and Li, Yan and Zhang, Lei and A, Lima and Yang, Chengcong and Zhao, Feiyan and Han, Haifeng and Shang, Dongyang and Yang, Fan and Zhang, Yuying and Zhang, Heping and Sun, Zhihong and Guo, Ruifang},
title = {Probio-X Relieves Symptoms of Hyperlipidemia by Regulating Patients’ Gut Microbiome, Blood Lipid Metabolism, and Lifestyle Habits},
journal = {Microbiology Spectrum},
year = {2023},
volume = {11},
number = {3},
doi = {10.1128/spectrum.04440-22}
}
EUVIMED